Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

AIFMD Seen as Most Unclear Regulatory Development in the Alternatives Industry

Thursday, January 26, 2012

Lord Paul Myners
Opalesque Industry Update - Over a third of delegates at a recent IMS Group (IMS) regulatory forum expressed the view that the Alternative Investment Fund Managers Directive, remains the most uncertain aspect of financial regulation in terms of its final substance and resultant effect on the industry.

The conference which was held at Bloomberg in London yesterday, played host to over two hundred delegates from the UK asset management and securities industry, including hedge fund managers, private equity firms, fund of funds, prime brokers and lawyers.

According to a survey conducted by IMS, the leading regulation and compliance consultancy, 31% of delegates found that AIFMD raises the most questions when considering the direct impact it will have on fund managers.

Additionally, nearly a quarter of delegates (23%) said that AIFMD will have the most impact in terms of direct cost and necessary change to operating and compliance procedures.

Delegates were also concerned about the impact of UK regulatory change (33%), FATCA (8%), SEC Registration (8%) and MiFID II (7%) on costs to businesses and on implementation of necessary changes to compliance and operating procedures.

Key note speaker Lord Paul Myners said: “The tide of regulation is only going to get stronger and the regulatory landscape will become even more difficult to negotiate. The process of AIFMD is a moveable feast with the ability to throw up constant surprises. The uncertainty surrounding financial regulation is enormous and it is impossible to fully comprehend the impact it will have on businesses. The buyside needs to get better at lobbying on regulation from the outset and actively engage with the regulators.”

Peter Moore, head of regulation at the IMS Group, said: “The results of the survey highlight the need for greater understanding of AIFMD and other regulatory regimes affecting the market. The cost/benefit reports of EU regulation are conspicuous by their absence.”

Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t